New Pharmaceuticals market report from TechNavio: "Global Choroidal Neovascularization (CNV) Market 2014-2018"

Boston, MA -- (ReleaseWire) -- 07/10/2014 --CNV is defined as a process in which new blood vessels grow in the choroid through the bruch membrane, which is the innermost layer of the choroid, and attack the sub-retinal space. Even though most causes are idiopathic, the known causes are related to degeneration, infections, choroidal tumors and/or trauma. As there is currently no medical treatment for this disease, this abnormal growth can easily lead to impairment of sight or complete loss of vision.

TechNavio's analysts forecast the Global CNV market will grow at a CAGR of 6.77 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global CNV market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of CNV

View Full Report Details and Table of Contents

TechNavio's report, the Global CNV Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global CNV market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

- Americas
- EMEA
- APAC

Key Vendors

- Bayer AG
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- Regeneron Pharmaceuticals Inc.

Other Prominent Vendors

- Affitech A/S
- Allergan Inc.
- Chengdu Kanghong Biotech Co. Ltd.
- Gilead Sciences Inc.
- Lpath Inc.
- Mat Biopharma SAS
- Pfizer Inc.
- Promedior Inc.
- QLT Inc.
- Quark Pharmaceuticals Inc.
- Resolvyx Pharmaceuticals Inc.
- Sanwa Kagaku Kenkyusho Co. Ltd.
- Valeant Pharmaceuticals International Inc.

Key Market Driver

- High Patient and Physician Satisfaction.
- For a full, detailed list, view our report.

Key Market Challenge

- High Cost of Treatment.
- For a full, detailed list, view our report.

Key Market Trend

- Strong Competition in the Market.
- For a full, detailed list, view our report.

Key Questions Answered in this Report

- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Affitech A/S, Allergan Inc., Chengdu Kanghong Biotech Co. Ltd., Gilead Sciences Inc., Lpath Inc., Mat Biopharma SAS, Pfizer Inc., Promedior Inc., QLT Inc., Quark Pharmaceuticals Inc., Resolvyx Pharmaceuticals Inc., Sanwa Kagaku Kenkyusho Co. Ltd., Valeant Pharmaceuticals International Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Choroidal Neovascularization - Pipeline Review, H1 2014
- Choroidal Neovascularization - Pipeline Review, H1 2013
- Corneal Neovascularization - Pipeline Review, H1 2014
- Corneal Neovascularization - Pipeline Review, H2 2013
- Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018
- Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2013
- Partnerships, Licensing, Investments and M&A Deals and Trends for April 2013 in Pharmaceuticals
- Partnerships, Licensing, Investments and M&A Deals and Trends for September 2013 in Pharmaceuticals
- Partnerships, Licensing, Investments and M&A Deals and Trends for August 2013 in Pharmaceuticals
- Global Medical Devices Survey 2013-2014 - Market Trends, Marketing Spend and Sales Strategies in the Global Medical Devices Industry